New aspects in the pathogenesis of dialysis-related amyloidosis: Role of β2-microglobulin modified with advanced glycation end products in bone and joint destruction

T. Miyata; K. Maeda

doi:10.1093/ndt/11.supp2.140

New aspects in the pathogenesis of dialysis-related amyloidosis: Role of β₂-microglobulin modified with advanced glycation end products in bone and joint destruction

T. Miyata, K. Maeda

MED - United Centers for Advanced Research and Translational Medicine (ART)

Research output: Contribution to journal › Article

5 Citations (Scopus)

Original language	English
Pages (from-to)	140-143
Number of pages	4
Journal	Nephrology Dialysis Transplantation
Volume	11
Issue number	SUPPL. 2
DOIs	https://doi.org/10.1093/ndt/11.supp2.140
Publication status	Published - 1996

ASJC Scopus subject areas

Nephrology
Transplantation

Access to Document

10.1093/ndt/11.supp2.140

Cite this

@article{663e2df675a14299b9f6a6a97f2ce6e0,

title = "New aspects in the pathogenesis of dialysis-related amyloidosis: Role of β2-microglobulin modified with advanced glycation end products in bone and joint destruction",

author = "T. Miyata and K. Maeda",

year = "1996",

doi = "10.1093/ndt/11.supp2.140",

language = "English",

volume = "11",

pages = "140--143",

journal = "Nephrology Dialysis Transplantation",

issn = "0931-0509",

publisher = "Oxford University Press",

number = "SUPPL. 2",

}

TY - JOUR

T1 - New aspects in the pathogenesis of dialysis-related amyloidosis

T2 - Role of β2-microglobulin modified with advanced glycation end products in bone and joint destruction

AU - Miyata, T.

AU - Maeda, K.

PY - 1996

Y1 - 1996

UR - http://www.scopus.com/inward/record.url?scp=0029894524&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029894524&partnerID=8YFLogxK

U2 - 10.1093/ndt/11.supp2.140

DO - 10.1093/ndt/11.supp2.140

M3 - Article

C2 - 8804015

AN - SCOPUS:0029894524

VL - 11

SP - 140

EP - 143

JO - Nephrology Dialysis Transplantation

JF - Nephrology Dialysis Transplantation

SN - 0931-0509

IS - SUPPL. 2

ER -